about
Analysis of Pre-Analytic Factors Affecting the Success of Clinical Next-Generation Sequencing of Solid Organ MalignanciesmicroRNA evaluation of unknown primary lesions in the head and neckOptimization and analysis of a quantitative real-time PCR-based technique to determine microRNA expression in formalin-fixed paraffin-embedded samples.mRNA transcript quantification in archival samples using multiplexed, color-coded probes.Factors affecting the success of next-generation sequencing in cytology specimens.Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis.PCR Techniques in Next-Generation Sequencing.Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?Recurrent genomic alterations in sequential progressive leukoplakia and oral cancer: drivers of oral tumorigenesis?Guidelines for the review of pathology in the research context.Clinical validation of a multipurpose assay for detection and genotyping of CALR mutations in myeloproliferative neoplasms.Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors.Quantitative detection of circulating epithelial cells by Q-RT-PCR.Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistry.MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.Hyperplastic polyposis and cancer of the colon with gastrinoma of the duodenum.Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD.Pathogenesis of follicular lymphoma.Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant.Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid TumorsNewly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasmsReproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11
P50
Q26783605-4B82A89C-867C-42AC-B118-B459FA0FC398Q33592209-0FAAD859-F381-4347-9A4B-F60562EC64D3Q33614363-411A9144-0197-41B6-A757-89F5838C6337Q33891675-25F8B0F3-E7B5-45C5-8C57-3ABC1490F2DBQ35730088-E08427CB-3EB9-45D1-8484-57C8FDE0F162Q35760876-D241EEBC-2A92-48D1-A720-07769CA8EFC7Q35914058-88298E01-E21E-425D-A69C-7168D81691FDQ35987244-AEEA8332-531B-483A-8C65-CA534E11C72BQ37708370-AFA8A9E1-AD0C-4B6D-A645-1A92C6143A2EQ38090129-089E20D0-1A2D-4638-B08D-760819272A40Q38826302-AF72278D-5084-48F1-9E5B-6BBC61B99EEFQ39037308-B87587A5-2FBB-49A1-8BD0-3B5CEB029A04Q40161469-6DDC5A2F-5E8A-4CCD-9EDE-32E572B038B3Q41507428-061CB4F1-7824-46C4-9927-665F10866ED4Q46466478-8E0B150E-C887-4C4D-AFC3-3ED6441F0DFFQ50781776-8F151DDC-E71B-477F-888E-292FFD418DD9Q51103234-54BC976A-F5F8-4988-BA0F-3BE32960312DQ52377802-A035CC90-7B57-4ACE-8E03-46A3541A824AQ53469467-077D6B34-0752-46DC-AA60-DA172F493D54Q58001833-BBBDC471-2F8C-4971-ABF5-CCEE09DFEE76Q58001836-31C178B3-EC74-480E-9B94-F529BEC848F6Q92893658-4F6AA5D0-E332-4E76-94D1-706B0D6D0026
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rashmi S. Goswami
@ast
Rashmi S. Goswami
@en
Rashmi S. Goswami
@es
Rashmi S. Goswami
@nl
Rashmi S. Goswami
@sl
type
label
Rashmi S. Goswami
@ast
Rashmi S. Goswami
@en
Rashmi S. Goswami
@es
Rashmi S. Goswami
@nl
Rashmi S. Goswami
@sl
prefLabel
Rashmi S. Goswami
@ast
Rashmi S. Goswami
@en
Rashmi S. Goswami
@es
Rashmi S. Goswami
@nl
Rashmi S. Goswami
@sl
P106
P1153
23018426600
P31
P496
0000-0001-6037-5582